Publication | Closed Access
Therapeutic response of patients with adult Still’s disease to biologic agents: multicenter results in Japan
55
Citations
26
References
2011
Year
Tocilizumab may be a promising biologic agent in refractory ASD.
| Year | Citations | |
|---|---|---|
Page 1
Page 1